Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Editorial Board Member: Gillery, Philippe / Kazmierczak, Steven / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Whitfield, John B.

12 Issues per year

IMPACT FACTOR 2013: 2.955
Rank 5 out of 29 in category Medical Laboratory Technology in the 2013 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR): 0.860
Source Normalized Impact per Paper (SNIP): 1.046



Multicenter evaluation of the hemolysis index in automated clinical chemistry systems

Giuseppe Lippi1, 9, 10 / Gian Luca Salvagno1 / Norbert Blanckaert2, 9 / Davide Giavarina3 / Sol Green4, 9 / Steve Kitchen5, 9 / Vladimir Palicka6, 9 / Anne J. Vassault7, 9 / Mario Plebani8–10, ,

1Clinical Chemistry Laboratory, University of Verona, Verona, Italy

2Laboratory Medicine, University Hospital Leuven, Leuven, Belgium

3Clinical Chemistry Laboratory, San Bortolo Hospital, Vicenza, Italy

4BD Diagnostics – Preanalytical Systems, New Jersey, USA

5Sheffield Hemophilia and Thrombosis Center, Royal Hallamshire Hospital, Sheffield, England

6Institute of Clinical Biochemistry and Diagnostics, Charles University, University Hospital, Hradec Kralove, Czech Republic

7Laboratoire de Biochimie B Hôpital Necker Enfants Malades, AP-HP, Paris, France

8Department of Laboratory Medicine, University of Padova, Padova, Italy

9EPSC – European Preanalytical Scientific Committee (www.specimencare.com)

10International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Patient's Safety

Corresponding author: Prof. Giuseppe Lippi, MD, Sezione di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Università degli Studi di Verona, Ospedale Policlinico G.B. Rossi, Piazzale Scuro, 10, 37134 Verona, Italy Phone: +39-045-8124308, Fax: +39-045-8201889, ;

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 47, Issue 8, Pages 934–939, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2009.218, June 2009

Publication History

Published Online:


Background: In vitro hemolysis, the prevailing cause of preanalytical error in routine laboratory diagnostics, might influence the reliability of several tests, affect the quality of the total testing process and jeopardize patient safety. Although laboratory instrumentation is now routinely equipped with systems capable of automatically testing and eventually correcting for hemolysis interference, to our knowledge there are no reports that have compared the efficiency of different analytical platforms for identifying and classifying specimens with hemolysis.

Methods: Serum from a healthy volunteer was spiked with varying amounts of hemolyzed blood from the same volunteer, providing a serum free hemoglobin concentration ranging from 0.0 g/L to 2.0 g/L as measured by the reference cyanmethemoglobin assay. The spiked serum samples were shipped to seven separate laboratories and the hemolysis index (HI) was tested in triplicate on the following analytical platforms: Roche Modular System P (n=4) and Integra 400 Plus (n=1), Siemens Dimension RxL (n=3), ADVIA 2400 (n=1) and ADVIA 1800 (n=1), Olympus AU 680 (n=1) and Coulter DXC 800 (n=1).

Results: Satisfactory agreement of HI results was observed among the various analytical platforms, despite a trend toward overestimation by the ADVIA 2400 and 1800. After normalizing results according to the instrument-specific alert value, discrepancies were considerably reduced. All instruments except for the Dimension RxL gave values normalized to the instrument-specific alert value, <1.0 for the sample with 0.048 g/L free hemoglobin, and >1.0 for the sample with 0.075 g/L free hemoglobin. The results of the four Modular System P tests were also highly reproducible among the different facilities. When evaluating instruments that provided quantitative HI results, the mean intra-assay coefficient of variation (CV) calculated for the triplicate determinations was always between 0.1% and 2.7%.

Conclusions: The results of this multicenter evaluation confirm that efficiency of different analytical platforms to correctly identify and classify unsuitable samples is satisfactory. However, more effort should be placed on the standardization of reporting HI. All the instruments that we tested provide either quantitative or qualitative results that are essentially comparable, but which should always be compared with the instrument-specific alert values to harmonize their efficiency.

Clin Chem Lab Med 2009;47:934–9.

Keywords: errors; hemolysis; hemolysis index (HI); patient safety; preanalytical variability

Comments (0)

Please log in or register to comment.